Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 14;11(1):17.
doi: 10.1186/s12348-021-00248-0.

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia

Daiki Sakai  1   2 , Wataru Matsumiya  3 , Sentaro Kusuhara  1 , Makoto Nakamura  1
Affiliations

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia

Daiki Sakai et al. J Ophthalmic Inflamm Infect. .

Abstract

Purpose: To evaluate the factors associated with the development of ocular candidiasis (OC) and ocular prognosis with echinocandin therapy for candidemia.

Methods: The medical records of 56 consecutive patients with a positive blood culture for Candida species between November 2016 and October 2019 were retrospectively reviewed. Information on patient characteristics, isolated Candida species, treatment details for candidemia, and ocular findings were extracted to identify factors associated with OC development.

Results: The leading pathogen of candidemia was Candida albicans (C.albicans) (41.1%). Of 56 patients, 18 (32.1%) were diagnosed with chorioretinitis, categorized as either probable (8 patients) or possible OC (10 patients). There was no case of endophthalmitis with vitritis. The incidence of probable OC was not significantly different between the groups treated with echinocandins and other antifungal drugs (15.2% vs. 11.1%, p = 1.00). In all probable OC cases, systemic antifungal therapy was switched from echinocandins to azoles, and no case progressed to endophthalmitis. A multivariate logistic analysis revealed that female sex (adjusted odds ratio [aOR], 8.93; 95% confidence interval [CI], 1.09-72.9) and C. albicans (aOR, 23.6; 95% CI, 1.8-281) were independent factors associated with the development of probable OC.

Conclusion: One-seventh of patients with candidemia developed probable OC. Given the evidence of female and C. albicans as the factors associated with OC development, careful ophthalmologic management is required with these factors, especially in candidemia. Although echinocandins had no correlation with OC development and did not lead to the deterioration of ocular prognosis, further investigation is required.

Keywords: Candida albicans; Candidemia; Chorioretinitis; Echinocandins; Endogenous endophthalmitis; Endophthalmitis; Ocular candidiasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Hassan I, Powell G, Sidhu M, Hart WM, Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. J Inf Secur. 2009;59(5):360–365. doi: 10.1016/j.jinf.2009.08.020. - DOI - PubMed
    1. Papadimitriou-Olivgeris M, Spiliopoulou A, Kolonitsiou F, Bartzavali C, Lambropoulou A, Xaplanteri P, Anastassiou ED, Marangos M, Spiliopoulou I, Christofidou M. Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009–2017) in a university Greek hospital. Infection. 2019;47(2):209–216. doi: 10.1007/s15010-018-1217-2. - DOI - PubMed
    1. Raja NS. Epidemiology, risk factors, treatment and outcome of Candida bloodstream infections because of Candida albicans and Candida non-albicans in two district general hospitals in the United Kingdom. Int J Clin Pract. 2020;75(1):e13655. doi: 10.1111/ijcp.13655. - DOI - PubMed
    1. Goemaere B, Becker P, Wijngaerden EV, et al. Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals. Mycoses. 2018;61(2):127–133. doi: 10.1111/myc.12714. - DOI - PubMed
    1. Mencarini J, Mantengoli E, Tofani L, Riccobono E, Fornaini R, Bartalesi F, Corti G, Farese A, Pecile P, Boni L, Rossolini GM, Bartoloni A. Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period. Infection. 2018;46(4):469–476. doi: 10.1007/s15010-018-1139-z. - DOI - PubMed

LinkOut - more resources